Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$26.48−2.20 (-7.67%)
Close on Nov 20, 2026Market cap $1.84BP/E –Yield –
Alamar Biosciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$15.20M | – |
| Q2 FY2026 | Jun 30, 2026 | -$14.96M | – |
| Q1 FY2026 | Mar 31, 2026 | -$20.95M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.36M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.64M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.62M | – |
See a number that looks wrong?